M3 stock

2413 · TSE · JPY

Compare M3
¥1,820.50Change from previous close: −0.63%Absolute change: −¥11.50

Close · November 16, 2026

Price history

−31.92% over the period

1 year: from ¥2,674.00 (November 17, 2025) to ¥1,820.50 (November 16, 2026), −31.92%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026¥1,820.50
October 30, 2026¥1,840.50
September 30, 2026¥1,753.50
August 31, 2026¥1,834.00
July 31, 2026¥1,781.50
June 30, 2026¥1,815.00
May 29, 2026¥1,424.00
April 30, 2026¥1,504.00
March 31, 2026¥1,605.50
February 27, 2026¥1,718.00
January 30, 2026¥1,910.50
December 30, 2025¥2,114.00
November 28, 2025¥2,577.00
November 17, 2025¥2,674.00

At a glance

  • The company

    Provides internet-based medical services including professional networks, recruitment platforms, clinical trials, and healthcare institution support

  • Latest results

    Quarter to September 30, 2026 · EPS ¥16.38 (estimate ¥18.84)

TickerLandia's take on M3

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low¥1,297.00
52-wk high¥2,746.00

−33.70% from the 52-week high

Analysts · 12 analysts

Average target¥1,944.17+6.79% vs. price

Buy 5 · Hold 7 · Sell 0 · Buy

TickerLandia Fingerprint: M3

Compared with similar companies: very high financial strength.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

M3 is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), M3's P/E today is 25.1, below the median of its last 10 fiscal years (51.7; between 22.1 and 136.0 from 2017 to 2026). M3's Forward P/E: 25.6, −13% against the median of a group of 5 similar companies (29.4).

P/E compared with its history

Compared with 5 similar companies

M3's metrics compared with similar companies
MetricM3Position in the groupBand
Forward P/E25.6Middle
Operating margin19.5%Middle
ROE11.8%Middle
Debt/equity0.08Middle
Price/book3.00Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: M3. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥91.75B

Latest quarter · Q3 2026

Net income

¥10.92B

Latest quarter · Q3 2026

Quarterly net margin

11.9%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
¥1.22T
P/E
26.5
EPS
¥69.01
Volume
1.74M
Daily trading
€35.5M
Dividend yield
1.21%
Last ex-dividend on March 30, 2026

How M3 is changing

All results
  • Revenue grew 15.7% a year on average over the last 5 years

  • Operating margin fell from 30.5% to 20.1%

  • Profits turn into cash: free cash flow equal to 119% of net income

Returns

M3 returns with dividends

¥1,000 invested in M3 5 years ago, on November 16, 2021, would be worth ¥291 today with dividends reinvested: −70.89% in total, −21.88% per year. On price alone it would be ¥278 (−72.17%).

PeriodM3Nikkei 225¥1,000 becomes
1 month−4.74%−6.39%¥953
6 months+34.35%−0.42%¥1,344
Year to date−13.88%+21.48%¥861
1 year−30.97%+21.52%¥690
3 years−23.32%+82.95%¥767
5 years−70.89%+105.15%¥291
10 years+32.20%+242.35%¥1,322

Over the last 6 months it has done better than 74% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment

The chart in detail

M3: technical analysis

M3 shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 82.8% below its all-time closing high (¥10,565.00, January 25, 2021).

Trend
No clear trend
RSI (14 sessions)
47
Between 30 and 70
vs 200-session average
+6.63%

Support and resistance

Price areas where M3 has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance¥2,166.75+19.02%2 touches, last on January 13, 2026
  2. Resistance¥1,966.00+7.99%3 touches, last on October 23, 2026
  3. Resistance¥1,863.50+2.36%2 touches, last on September 1, 2026
  4. Last price¥1,820.50
  5. Support¥1,724.00−5.30%4 touches, last on October 2, 2026
  6. Support¥1,670.00−8.27%2 touches, last on August 25, 2026
  7. Support¥1,604.83−11.85%3 touches, last on September 10, 2026

Volatility and risk

Over the last year it has moved little with the Nikkei 225.

Beta (1 year) vs Nikkei 225
0.05
Volatility (60 sessions, annualised)
33.8%
Largest fall in the last year
−50.88%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

M3: seasonality

Average monthly price change over 23 years

+3.4%Jan+0.5%Feb+2.7%Mar+3.5%Apr+0.8%May+3.7%Jun+3.9%Jul−0.1%Aug+1.0%Sep+1.3%Oct+3.9%Nov−2.2%Dec

Over the last 23 years, the strongest month for M3 has been July: +3.90% on average, positive in 13 years out of 22. The weakest has been December: −2.21% on average, positive in 5 years out of 22. November, the current month, has been positive in 11 years out of 22 (+3.89% on average).

Show chart data
MonthAverageMedianPositive years
January+3.36%+4.51%15 of 22
February+0.48%−1.63%9 of 22
March+2.73%−0.04%11 of 22
April+3.50%+3.70%15 of 22
May+0.83%+3.11%12 of 22
June+3.73%+1.95%16 of 22
July+3.90%+3.64%13 of 22
August−0.06%−1.36%10 of 22
September+0.99%+3.22%12 of 22
October+1.33%−0.41%11 of 23
November+3.89%+0.22%11 of 22
December−2.21%−2.78%5 of 22

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

M3 and its competitors

Physicians and other healthcare professionals in Japan, the United States and the United Kingdom form the core audience of M3, Inc., which reaches them over the internet. Its members-only platform m3.com offers information, tools and services, alongside MR-kun, which delivers current medical information for daily practice, and the job sites m3.com CAREER and Yakucari for physicians and pharmacists. The company also runs online lectures, clinical trial and research services, survey panels, and the public question service AskDoctors, where registered doctors answer health questions.

Headquarters
Tokyo, Japan
Employees
17,010
Founded
2000
Chief executive
Itaru Tanimura
M3 and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
M32413$7.61B19.5%26.5+34.35%
Pro MedicusPME$14.57B74.9%81.4+65.15%
XtalPi Holdings2228$3B-124.6%—−32.46%
4DMedical4DX$940.03M-813.7%—−47.48%
DoximityDOCS$5.95B27.1%46.3+42.54%
Tempus AITEM$13.06B-18.5%—+55.99%

Same industry or related industries, similar size. Compare M3 with its competitors · Full profile